Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the filing of a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) for the proposed initial public offering of Cortigent, Inc. (“Cortigent”). Cortigent, currently a wholly-owned … [Read more…]

Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors

The removal of the age restriction and inclusion of type 2 diabetes will enable more people with diabetes to access Dexcom’s real-time CGM System – the standard of care in diabetes management BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its … [Read more…]

NUCLIDIUM and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNETTM in Neuroendocrine Tumours

BASEL, Switzerland–(BUSINESS WIRE)–NUCLIDIUM today announced that the Neuroendocrine Tumors Research Foundation (“NETRF”) has selected the company and its collaboration partner the University Hospital Basel (Universitätsspital Basel, “USB”) as recipients of its Investigator Award. The grant will support the initiation and execution of a Phase 1 clinical trial with TraceNETTM , a novel copper-based radiodiagnostic for … [Read more…]

RWS Supports Project to Renovate and Modernize the Operating Theatre at The Christian Hospital, Indore

Modern, state-of-the-art facility becomes centre of medical excellence for local community CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, is proud to partner with The Christian Hospital in Indore, India, and help transform its main operating theatre into a modern environment that provides medical excellence to … [Read more…]

Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market

Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and safety assurance than ever before. OXFORD, England–(BUSINESS WIRE)–Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational … [Read more…]

Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer

SINGAPORE–(BUSINESS WIRE)–Prestige Biopharma has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary name: Ulenistamab), in the treatment of unresectable or metastatic pancreatic adenocarcinoma (PDAC) that has relapsed following and/or is refractory to at least one line of prior therapy. PBP1510 targets Pancreatic Adenocarcinoma Upregulated Factor (PAUF), a … [Read more…]

Belmont Village Senior Living and Author Connie Baher Present “An Emotional Survival Guide for Caregivers”

A Webinar Discussion and Q&A Offers Support to Caregivers, Addresses Issues Commonly Faced, and Helpful Strategies for Managing the Challenging Role LA JOLLA, Calif.–(BUSINESS WIRE)–On March 2nd, Belmont Village Senior Living’s Founder and CEO, Patricia Will, moderated a webinar like her book titled “An Emotional Survival Guide for Caregivers.” presented by author Connie Baher. Her … [Read more…]

MedX Health Announces Final Closing of Secured Convertible Debenture Financing

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that it has completed the Final Closing of Secured Convertible Debentures previously announced in its Press Release dated January 30, 2023. The final Closing, which was completed on March 17, 2023, comprised issuance of … [Read more…]

Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights

The Harmonic™ clinical trial, a Phase 2 study in never-smoker patients with non-small lung cancer, has activated 5 clinical trial sites, across 12 locations, and anticipates multiple additional sites in the US during the 1st half of 2023; first enrolled patients are anticipated for Q2 2023. IND-enabling studies for LP-184 are completed, and submission of … [Read more…]

CWCI Documents Recent California Workers’ Comp Professional Medical Service Treatment Patterns

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–A new study finds treatment patterns for California workers’ comp professional medical services have stabilized in recent years, with only minor changes in the utilization rates and volume of services rendered to injured workers within the first two years for indemnity claims with 2014 through 2019 initial treatment dates, and within the first … [Read more…]